Developer docs
API playgroundTry for free, no card

Search company profiles

Atlantis Health

Full company profile

uuid0008xhg

Namestring
Atlantis Health
Legal namestring
Atlantis Health
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Atlantis Health is a private, New Zealand-headquartered behaviour change and patient engagement company founded in 1996. The firm designs, develops and delivers tailored multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations, with a stated mission of improving medication adherence and health behaviours among patients managing long-term conditions. Its offerings span four modules aligned to the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel digital engagement platform that combines health psychology, behavioural science and co-design with patients and providers.

The underlying technology is grounded in evidence-based health psychology rather than AI or machine learning; the platform leverages data-driven personalization and multichannel delivery (digital and human touchpoints) to operationalize behaviour change interventions. Atlantis Health's approach rests on three pillars: applying health psychology and behavioural science, co-designing experiences with patients and HCPs, and deploying data-driven digital platforms for multichannel engagement. The firm cites published research, case studies (e.g., integrated patient support for psoriatic disease, global oncology patient study) and a behavioural science leadership team (Dr. Kate Perry, Group Behavioural Science Director) as evidence of its scientific depth.

Atlantis Health operates a B2B enterprise go-to-market model, engaging directly with 11 of the world's largest pharmaceutical companies — AbbVie, Bayer, GSK, Janssen, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and Merck — as well as NZ Blood. Solutions are delivered at both global and local levels across 30+ countries. Revenue is generated through professional services contracts (project or retainer-based engagements) tailored to each client's therapy area and brand objectives; pricing is not publicly disclosed. Cumulative disclosed funding is approximately $46M across rounds in 2010 ($14.27M) and 2014 ($32M, led by Callaghan Innovation), after which the 251-500 employee company appears to have continued operating and scaling without subsequent disclosed external capital raises.

Short descriptiontext

Atlantis Health is a New Zealand-based, private behaviour change company that designs and delivers multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations across 30+ countries, with a focus on improving medication adherence and health outcomes for patients with long-term conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAuckland, New Zealand
HQ citystring
Auckland
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
patient engagement solutions, behavior change solutions, medication adherence programs, patient support services, health psychology services
Industry3 codes
1Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
CodeHLALAIAGPrimaryYes
2Patient App, Adherence & Engagement for RPM Programs
CodeHLACAFAJPrimaryNo
3Patient Access Programs & Affordability (Copay/Hubs/PSP)
CodeHLAIAKAGPrimaryNo
NAICS code1 code
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Health Services8000
Product category
Patient Engagement Solutions
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Engagement Solutions
TypeProfessional Services
Description

Provides tailored, multichannel patient engagement solutions to pharmaceutical, biotech and healthcare organisations. Services span across the patient health journey from pre-diagnosis through illness self-management. Revenue likely derived from service contracts with pharmaceutical and healthcare clients, potentially on a project or retainer basis.

atlantishealth.com:443
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Atlantis Health designs and delivers tailored, multichannel patient engagement and behaviour change solutions for pharmaceutical, biotech and healthcare organisations. Using health psychology and behavioural science, the company improves medication adherence and health behaviours of people managing long-term health conditions across the patient journey, from pre-diagnosis through diagnosis acceptance, treatment initiation, and illness self-management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Engaged patients show 8-21% lower healthcare costs
+1 more record
Product overview1 text field

Atlantis Health offers a unified patient engagement platform designed for pharmaceutical, biotech and healthcare organizations. The platform combines behavioral science, co-design with patients and providers, and data-driven digital engagement tools. The core offering includes modules across four stages of the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel engagement platform that delivers personalized behavior change interventions.

Product and service1 record
1Patient Engagement Solutions Platform
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for long-term health conditions. AbbVie is listed among the world's leading pharmaceutical companies served by Atlantis Health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner working with Atlantis Health on patient engagement solutions. Listed as one of the leading pharmaceutical clients served across their global operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for patients managing long-term conditions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner (Janssen Pharmaceutical Companies of Johnson & Johnson) engaged with Atlantis Health for patient engagement solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eli Lilly and Company partner working with Atlantis Health on patient engagement solutions for long-term health conditions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner working with Atlantis Health on patient engagement solutions across global operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner engaged with Atlantis Health for patient engagement and behaviour change solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner collaborating with Atlantis Health on patient engagement solutions.

10UCB
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner working with Atlantis Health on patient engagement and behaviour change solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner (Merck KGaA / Merck & Co.) engaged with Atlantis Health for patient engagement solutions.

12NZ Blood
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare organization partner collaborating with Atlantis Health on patient engagement solutions in New Zealand.

atlantishealth.com:443
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Atlantis Health

Patient Engagement Solutionsatlantishealth.com

Atlantis Health is a New Zealand-based, private behaviour change company that designs and delivers multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations across 30+ countries, with a focus on improving medication adherence and health outcomes for patients with long-term conditions.

What Atlantis Health does

Atlantis Health is a private, New Zealand-headquartered behaviour change and patient engagement company founded in 1996. The firm designs, develops and delivers tailored multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations, with a stated mission of improving medication adherence and health behaviours among patients managing long-term conditions. Its offerings span four modules aligned to the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel digital engagement platform that combines health psychology, behavioural science and co-design with patients and providers.

The underlying technology is grounded in evidence-based health psychology rather than AI or machine learning; the platform leverages data-driven personalization and multichannel delivery (digital and human touchpoints) to operationalize behaviour change interventions. Atlantis Health's approach rests on three pillars: applying health psychology and behavioural science, co-designing experiences with patients and HCPs, and deploying data-driven digital platforms for multichannel engagement. The firm cites published research, case studies (e.g., integrated patient support for psoriatic disease, global oncology patient study) and a behavioural science leadership team (Dr. Kate Perry, Group Behavioural Science Director) as evidence of its scientific depth.

Atlantis Health operates a B2B enterprise go-to-market model, engaging directly with 11 of the world's largest pharmaceutical companies — AbbVie, Bayer, GSK, Janssen, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and Merck — as well as NZ Blood. Solutions are delivered at both global and local levels across 30+ countries. Revenue is generated through professional services contracts (project or retainer-based engagements) tailored to each client's therapy area and brand objectives; pricing is not publicly disclosed. Cumulative disclosed funding is approximately $46M across rounds in 2010 ($14.27M) and 2014 ($32M, led by Callaghan Innovation), after which the 251-500 employee company appears to have continued operating and scaling without subsequent disclosed external capital raises.

Atlantis Health firmographics

Firmographics
Name
Atlantis Health
Legal name
Atlantis Health
Website
https://atlantishealth.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Atlantis Health is a New Zealand-based, private behaviour change company that designs and delivers multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations across 30+ countries, with a focus on improving medication adherence and health outcomes for patients with long-term conditions.
Ownership category
akta.pro rank

Atlantis Health industry classification

Industry
Product category
Patient Engagement Solutions
NAICS
Other Scientific and Technical Consulting Services (541690)
SIC
Services-Health Services (8000)
akta.pro primary industry
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
akta.pro secondary industries
Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ), Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)

Keywords

  • Patient engagement solutions
  • Behavior change solutions
  • Medication adherence programs
  • Patient support services
  • Health psychology services

Where Atlantis Health is headquartered

Location

Headquarters

HQ city
Auckland
HQ country
New Zealand
HQ region
Oceania

Markets served

Atlantis Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Patient Engagement Solutions: Provides tailored, multichannel patient engagement solutions to pharmaceutical, biotech and healthcare organisations. Services span across the patient health journey from pre-diagnosis through illness self-management. Revenue likely derived from service contracts with pharmaceutical and healthcare clients, potentially on a project or retainer basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Atlantis Health product offering

Product offering

Core offering

Atlantis Health designs and delivers tailored, multichannel patient engagement and behaviour change solutions for pharmaceutical, biotech and healthcare organisations. Using health psychology and behavioural science, the company improves medication adherence and health behaviours of people managing long-term health conditions across the patient journey, from pre-diagnosis through diagnosis acceptance, treatment initiation, and illness self-management.

Product overview

Atlantis Health offers a unified patient engagement platform designed for pharmaceutical, biotech and healthcare organizations. The platform combines behavioral science, co-design with patients and providers, and data-driven digital engagement tools. The core offering includes modules across four stages of the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel engagement platform that delivers personalized behavior change interventions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Engagement Solutions Platform

Quantifiable outcome

  • Engaged patients show 8-21% lower healthcare costs
  • +1 more outcomes

Companies that use Atlantis Health

Customer profile

Named customers12 records

Segments2 records

Ideal customer profiles2 records

Atlantis Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Atlantis Health partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core.

  • AbbViecoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for long-term health conditions. AbbVie is listed among the world's leading pharmaceutical companies served by Atlantis Health.
  • BayercoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement solutions. Listed as one of the leading pharmaceutical clients served across their global operations.
  • GSKcoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for patients managing long-term conditions.
  • JanssencoreStrategic or Co-development PartnerPharmaceutical partner (Janssen Pharmaceutical Companies of Johnson & Johnson) engaged with Atlantis Health for patient engagement solutions.
  • LillycoreStrategic or Co-development PartnerEli Lilly and Company partner working with Atlantis Health on patient engagement solutions for long-term health conditions.
  • NovartiscoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions.
  • RochecoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement solutions across global operations.
  • SanoficoreStrategic or Co-development PartnerPharmaceutical partner engaged with Atlantis Health for patient engagement and behaviour change solutions.
  • TakedacoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement solutions.
  • UCBcoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement and behaviour change solutions.
  • MerckcoreStrategic or Co-development PartnerPharmaceutical partner (Merck KGaA / Merck & Co.) engaged with Atlantis Health for patient engagement solutions.
  • NZ BloodcoreStrategic or Co-development PartnerHealthcare organization partner collaborating with Atlantis Health on patient engagement solutions in New Zealand.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Atlantis Health competitors and assessment

Company assessment

Market position

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Atlantis Health social profiles

Digital presence

Atlantis Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Atlantis Health leadership team

Management profile

Number of profiles

Profiles3 records

Atlantis Health funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Atlantis Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlantis Health

What does Atlantis Health do?

Atlantis Health designs and delivers tailored, multichannel patient engagement and behaviour change solutions for pharmaceutical, biotech and healthcare organisations. Using health psychology and behavioural science, the company improves medication adherence and health behaviours of people managing long-term health conditions across the patient journey, from pre-diagnosis through diagnosis acceptance, treatment initiation, and illness self-management.

Is Atlantis Health a public or private company?

Atlantis Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Atlantis Health founded?

Atlantis Health was founded in 1996. It employs 101 to 250 people.

Where is Atlantis Health based?

Atlantis Health is headquartered in Auckland, New Zealand, in the Oceania region.

How does Atlantis Health make money?

One revenue line is on record: patient Engagement Solutions.

Does Atlantis Health have an API?

No public API is recorded for Atlantis Health.

What industry is Atlantis Health in?

Atlantis Health's product category is Patient Engagement Solutions. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM), with a secondary code of HLACAFAJ, Patient App, Adherence & Engagement for RPM Programs. Its NAICS code is 541690 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireDigital Health Coaching Market Report 2025-2030, with Profiles of Atlantis Health, Naluri Therapeutics, Noom, Lark Technologies, Omada Health, Avidon Health, Quartet Health, Lyra Health & moreThe Digital Health Coaching Market, valued at USD 10.99 billion in 2024, is projected to reach USD 22.06 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.51%. Key factors driving this growth include favorable government initiatives, increasing health consciousness, and a rise in the prevalence of chronic diseases. North America is expected to dominate the market due to the presence of major players and high adoption of advanced technologies.PR NewswirePatients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38%A study published in the Patient Preference and Adherence journal demonstrates that personalized patient support programs significantly improved treatment persistence rates among patients with neovascular age-related macular degeneration (nAMD), with 88% persistence at 24 months compared to 64% under usual care. The research, conducted by Atlantis Healthcare through its SmartSight program sponsored by Bayer Australia, showed a 38% improvement in treatment adherence when patients received tailored information and nurse-led coaching calls addressing their individual beliefs and barriers. The findings suggest that understanding patients' unique psychological and practical challenges could help address the global medication non-adherence problem, which the industry could save an estimated $269 billion by improving.PR NewswireAtlantis Healthcare Takes Best Persistence/Adherence Program At The 2019 PM360 Trailblazer AwardsAtlantis Healthcare was named a 2019 PM360 Trailblazer Gold Award winner for Best Persistence/Adherence program, shared with Intercept Pharmaceuticals, for the Interconnect Support Services patient support program that helps patients adhere to OCALIVA treatment for Primary Biliary Cholangitis. The award recognizes outstanding achievement and innovation in healthcare marketing, with winners selected by the PM360 Editorial Advisory Board. The award ceremony was held at Gotham Hall in New York on September 19, 2019.PR NewswireAtlantis Healthcare US Announces Expanded Capabilities In Providing Full-Service Personalized Health SolutionsAtlantis Healthcare US announced three new hires representing a strategic shift from a patient support program house to a full-service agency, adding digital, creative, and account management capabilities. The expansion, led by US Country Manager Amy Parke, aims to leverage over 20 years of health psychology expertise across a broader business scope spanning pre-diagnosis to treatment and self-management. CEO Jonny Duder, based in New Zealand, will guide the new model and US market strategy as the company positions itself as an innovative leader in the patient space globally.PR NewswireAtlantis Healthcare Evolves Health Psychology Approach To Optimise Medication Adherence Research and SolutionsAtlantis Healthcare announced adoption of the Intentional Non-Adherence Scale (INAS), a new health psychology assessment tool developed by Professors John Weinman and Keith Petrie to better understand why patients choose not to take their medication as prescribed. The 22-item scale identified two previously unrecognised factors—"Resisting Illness" and "Testing Treatment"—that expand current theoretical frameworks and could improve the effectiveness of patient support programmes. The company is now working with healthcare stakeholders to leverage this tool to assess and optimise adherence programmes globally.PR NewswireAtlantis Healthcare Announces New Executive Leadership To Drive Global Innovation And Expansion In Personal Health SolutionsAtlantis Healthcare, a global health psychology and behavioral science company, announced executive leadership changes including the appointment of co-founder Jonny Duder as CEO alongside the hiring of Amy Parke as US Country Manager, Connor Holmes as Australia Country Manager, and Nathan O'Donnell as New Zealand Country Manager. The company stated it will focus on expanding its personalized health intervention approach using scalable technologies such as chatbots, voice, and AI to enhance behavioral prediction and personalization for pharma/biotech brands, payers, and healthcare systems. Atlantis Healthcare operates regional hubs in the US, UK, Germany, Australia, and New Zealand.PR NewswireAtlantis Healthcare Wins Gold PM360 Trailblazer Award for Best Persistence/Adherence ProgramAtlantis Healthcare won a PM360 Trailblazer Gold Award in the Best Persistence/Adherence Program category for the Inspire+ App patient support initiative, in partnership with Pixel Light Digital Media and Jazz Pharmaceuticals. The Inspire+ App is a free digital tool designed to help patients adhere to complex dosing regimens when prescribed Jazz Pharmaceuticals' treatments, with Atlantis Healthcare applying health psychology-based research and behavior change techniques to its development. This marks Atlantis Healthcare's second consecutive Gold win in this category, following a 2017 award for the Takeda Oncology NINLARO® Empower program with Ashfield Healthcare.PR NewswireAtlantis Healthcare publie un livre blanc sur l’amélioration de l’alliance thérapeutiqueAtlantis Healthcare Ltd., a global leader in patient behavior change and self-management programs, published a white paper examining how collaborative communication between healthcare professionals and patients—known as therapeutic alliance—can improve chronic disease management outcomes. The report also explores the role pharmaceutical companies can play in overcoming barriers to effective patient communication and includes discussion guides developed by Atlantis Healthcare's clinical staff. The white paper identifies key factors for building effective therapeutic alliances, including patient self-management tools, proper positioning of patient journey materials, and training for healthcare professionals.PR NewswireAtlantis Healthcare emite un documento sobre las mejoras de la alianza terapéuticaAtlantis Healthcare Ltd., a global leader in patient behavior change and self-treatment programs, published a white paper on October 31, 2017 examining how collaborative communication between healthcare professionals and patients—termed therapeutic alliance—can improve patient outcomes when considering patient needs and preferences. The document also explores the role pharmaceutical companies can play in overcoming barriers to effective patient communication during consultations and treatment. The paper includes guidance developed by Atlantis Healthcare to help healthcare professionals address patient needs using a biopsychosocial approach.PR NewswireAtlantis Healthcare Issues White Paper on Enhancing Therapeutic AllianceAtlantis Healthcare Ltd., a global leader in patient self-management programs, released a white paper examining how collaborative communication between healthcare professionals and patients can improve treatment outcomes in chronic illness. The paper specifically explores the role of pharmaceutical companies in addressing barriers to effective patient communication and outlines a biopsychosocial approach to building therapeutic alliances. The company is making the white paper available for download as part of its effort to promote best-in-class patient self-management solutions.